Inflammatory Bowel Disease
Conditions
Interventions
Index test:anti-CABP, 
pANCA, 
ASCA
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with IBD were divided into two groups 1. 18 years old <= subject age <= 80 years old; 2. According to the consensus on diagnosis and treatment of inflammatory bowel disease (2018 Edition), the patients with IBD were definitely diagnosed according to the results of clinical symptoms, imaging and pathology. Control group: gastrointestinal polyps control group 1. 18 years old <= subject age <= 80 years old; 2. Patients who received gastroscopy or colonoscopy and whose histopathological examination confirmed that they were gastrointestinal polyps.
Exclusion criteria
Exclusion criteria: Patients with IBD group: 1. Patients with malignant tumor and recent chemoradiotherapy. 2. Patients with infectious diarrhea. 3. Patients with uncertain inflammatory bowel disease. 4. Pregnant or lactating patients. Control group: gastrointestinal polyps control group: 1. Patients with IBD could not be excluded by gastroenteroscopy and / or histopathological examination. 2. Pregnant or lactating patients. 3. Patients with poor physical fitness have severe heart / brain / lung functional diseases, or combined with hematological / rheumatic immune system diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| anti-Crohn's disease antibody binding polypeptide;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactMei Qiao
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed